ArticleBMC oral health2026
Ultrasound-guided simultaneous lateral pterygoid muscle and bilaminar zone injection to treat temporal mandibular joint anterior disc displacement with reduction.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAnterior disc displacement with reduction (ADDwR) most frequently occurs in temporomandibular joint disorder (TMD) and poses a major clinical challenge. Both botulinum toxin (BTX) and hypertonic dextrose (HD) injections have been reported for the treatment of ADDwR. However, the clinical confirmation of precise injection into the lateral pterygoid muscle and bilaminar zone is difficult. This study evaluated ultrasound-guided injection of BTX and HD for the treatment of ADDwR.
methodsThirty patients with ADDwR received real-time ultrasound-guided injection of 30 units of BTX and 0.2 ml of 50% HD. Primary outcomes included Visual Analogue Scale (VAS) scores for joint pain and clicking, and maximum opening. The secondary outcome was the Fricton score, and data were collected before treatment, and at 1 month and 6 months post-treatment.
resultsAt 1 month, VAS scores for joint pain and clicking decreased significantly, maximum opening increased markedly, and Fricton scores also showed a significant reduction (P < 0.01). At the 6-month follow-up, improvements in maximum opening and joint clicking remained statistically significant, although the degree of improvement was reduced compared with the 1-month assessment (P < 0.05). In contrast, improvement in joint pain was no longer statistically significant (P = 0.369). The Palpation Index, Craniomandibular Index and Dysfunction Index still showed significant improvement (P < 0.05).
conclusionUltrasound-guided precision combined injection of BTX and HD represents a viable short-term therapeutic option for anterior disc displacement with reduction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.